Daniel S. Chao

RubrYc Therapeutics, Inc. develops antibody therapy applications. Its products include RubrYc Discovery Engine, through which people can decode protein interactions through the integration of data and biological science. The company was founded in 2017 and is headquartered in San Carlos, CA.

Palo Santo Inc (Palo Santo) is a venture capital firm founded in 2005 by Timothy J Schlidt and Daniel L. Goldberg. The firm is headquartered in New York.

Herophilus, Inc. operates as neurotherapeutics company. It employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. The firm combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. The company was founded by Frederic J. Kerrest, Sean Escola and Saul Kato and is headquartered in San Francisco, CA.

Halo Neuro, Inc. develops neuroscience based technology. It offers its products under the categories of fitness, sports, gaming, health, biotech, wearables and other consumer technology. The company was founded by Brett Wingeier, Amol R. Sarva, Lee M. von Kraus and Daniel S. Chao in 2013 and is headquartered in San Francisco, CA.

The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA.